These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2406377)

  • 1. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in the beta blocker heart attack trial: circumstances surrounding death.
    Peters RW; Byington R; Arensberg D; Friedman LM; Romhilt DW; Barker A; Laubach C; Wilner GW; Goldstein S
    J Chronic Dis; 1987; 40(1):75-82. PubMed ID: 3543049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia.
    Friedman LM; Byington RP; Capone RJ; Furberg CD; Goldstein S; Lichstein E
    J Am Coll Cardiol; 1986 Jan; 7(1):1-8. PubMed ID: 3510232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced changes in the QT interval duration and dispersion in patients with sudden cardiac death after myocardial infarction.
    Yi G; Crook R; Guo XH; Staunton A; Camm AJ; Malik M
    Int J Cardiol; 1998 Feb; 63(3):271-9. PubMed ID: 9578355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
    Peters RW
    Am J Cardiol; 1990 Nov; 66(16):57G-59G. PubMed ID: 2239715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction.
    Kostis JB; Byington R; Friedman LM; Goldstein S; Furberg C
    J Am Coll Cardiol; 1987 Aug; 10(2):231-42. PubMed ID: 2439559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta Blocker Heart Attack Trial: design features.
    Control Clin Trials; 1981 Dec; 2(4):275-85. PubMed ID: 6120793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraventricular tachyarrhythmias after coronary bypass surgery--a double blind randomized trial of prophylactic low dose propranolol.
    Martinussen HJ; Lolk A; Szczepanski C; Alstrup P
    Thorac Cardiovasc Surg; 1988 Aug; 36(4):206-7. PubMed ID: 2903581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of electrocardiographic persistent ST depression in patients with their first myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
    Gheorghiade M; Shivkumar K; Schultz L; Jafri S; Tilley B; Goldstein S
    Am Heart J; 1993 Aug; 126(2):271-8. PubMed ID: 8337995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am Heart J; 1991 Dec; 122(6):1548-53. PubMed ID: 1957749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
    Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA
    Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.
    Lichstein E; Morganroth J; Harrist R; Hubble E
    Circulation; 1983 Jun; 67(6 Pt 2):I5-10. PubMed ID: 6342839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.